Evidence map›Paper›PMID 19933849›Full record

ArticleMolecular and cellular biology2010

Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival.

Wen Qing Li, Tad Guszczynski, Julie A Hixon, Scott K Durum

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01368107 (A Randomised, Multicentric, Phase 2a Study Evaluating the Impact of an Immunotherapy by IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01368107 phase2completednot on this mapstarted 2011, after this paper: background citation

A Randomised, Multicentric, Phase 2a Study Evaluating the Impact of an Immunotherapy by IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

TypeinterventionalSponsorCentre Leon BerardRan2011 to 2014Enrolled24ConditionsMetastatic Breast CancerArmsplacebo, interleukin 7
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Cell death in sepsis: unveiling new perspectives on organ dysfunction.Frontiers in cell and developmental biology · 2026
    Review
  3. Review
  4. Advances in IL-7 Research on Tumour Therapy.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Article
  7. Interleukin (IL)-7 Signaling in the Tumor Microenvironment.Advances in experimental medicine and biology · 2021
    Article
  8. Article
  9. Review
  10. Role of cellular events in the pathophysiology of sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2016
    Review
  11. Review
  12. c-FLIP protects T lymphocytes from apoptosis in the intrinsic pathway.Journal of immunology (Baltimore, Md. : 1950) · 2015
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Wen Qing LiSection of Cytokines and Immunity, National Cancer Institute, Frederick, MD 21702-1201, USA.
Tad Guszczynski
Julie A Hixon
Scott K Durum
Center for Cancer Research · USNational Cancer Institute · US

Funding

Cytokines and T Cell DevelopmentZIABC009287 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DURUM, SCOTT · 2009 to 2025
$15.5M
Intramural NIH HHSNCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400
6 · The paper itself

Abstract

Interleukin-7 (IL-7) is critical for T-cell development and peripheral T-cell homeostasis. The survival of pro-T cells and mature T cells requires IL-7. The survival function of IL-7 is accomplished partly through induction of the antiapoptotic protein Bcl-2 and inhibition of proapoptotic proteins Bax and Bad. We show here that the proapoptotic protein Bim, a BH3-only protein belonging to the Bcl-2 family, also plays a role in peripheral T-cell survival. Deletion of Bim partially protected an IL-7-dependent T-cell line and peripheral T cells, especially cells with an effector memory phenotype, from IL-7 deprivation. However, T-cell development in the thymus was not restored in IL-7(-/-) Rag2(-/-) mice reconstituted with Bim(-/-) bone marrow. IL-7 withdrawal altered neither the intracellular location of Bim, which was constitutively mitochondrial, nor its association with Bcl-2; however, a reduction in its association with the prosurvival protein Mcl-1 was observed. IL-7 withdrawal did not increase Bim mRNA or protein expression but did induce changes in the isoelectric point of Bim(EL) and its reactivity with an antiphosphoserine antibody. Our findings suggest that the maintenance of peripheral T cells by IL-7 occurs partly through inhibition of Bim activity at the posttranslational level.

Indexed as

Adoptive TransferAnimalsApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11Cell LineCell SurvivalDNA-Binding ProteinsInterleukin-7Membrane ProteinsMiceMice, Inbred C57BLMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2T-LymphocytesApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11DNA-Binding ProteinsInterleukin-7Mcl1 protein, mouseMembrane ProteinsMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2Rag2 protein, mouseTumor Suppressor Protein p53

Identifiers

PMID19933849
PMCPMC2812241
OpenAlexW2096497265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.